Position in IMRX
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$613,770
-$30,224 QoQ
Shares Held
123,000
+0.7% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#32
of 111 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IMRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kingsview Wealth Management, LLC holds $4,094,329 across 12 Biotechnology names. IMRX ranks #2 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
25,674 | $1,001,542 | |
| 2 | IMRX |
Immuneering Corp
This page
|
123,000 | $613,770 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
2,120 | $518,912 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
675 | $420,889 | |
| 5 | RPRX |
Royalty Pharma plc
|
6,377 | $357,558 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
15,895 | $296,441 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
464 | $230,482 | |
| 8 | INSM |
INSMED Inc
|
2,147 | $228,913 |
All Filings in IMRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $613,770 | 123,000 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $643,994 | 122,200 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $780,388 | 118,600 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $630,000 | 90,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $47,180 | 14,000 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||